Skip to main content

Genus Capital Management Inc.

Position in GSK — GSK plc

CIK 1532385 VANCOUVER, A1

Position in GSK

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$640,048
-$50,378 QoQ
Shares Held
12,210
-2.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#429
of 1,032 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GSK Over Time

Shares Held

Position Value (USD)

Derivatives in GSK

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$338,774
PutShares
10,017

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Genus Capital Management Inc. holds $47,435,252 across 7 Drug Manufacturers - General names. GSK ranks #7 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GSK
GSK plc
This page
12,210 $640,048

All Filings in GSK

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $640,048 12,210
2026-03-31 $690,426 12,510
2025-12-31 $592,403 12,080
2025-09-30 $412,609 9,560
2025-06-30 $358,656 9,340
2025-03-31 $380,039 9,810
2024-12-31 $338,774 10,017
2024-09-30 $409,494 10,017
2024-06-30 $348,694 9,057
2024-03-31 $396,333 9,245
2023-12-31 $327,981 8,850
2023-09-30 $520,187 14,350
2023-06-30 $511,434 14,350